Experimental cholesterol-lowering drug effective at lowering bad cholesterol, study shows

PHILADELPHIA -- Twice-yearly injections of an experimental cholesterol-lowering drug, inclisiran, were effective at reducing low-density lipoprotein (LDL) cholesterol, often called bad cholesterol, in patients already taking the maximum dose of statin drugs, according to data of the ORION-10 trial presented Saturday, Nov. 16, at the American Heart Association's Scientific Sessions 2019. High levels of LDL [...]
Source: Mayo Clinic Research News - Category: Research Source Type: news